Co-Authors
This is a "connection" page, showing publications co-authored by Stefan Pöhlmann and Inga Nehlmeier.
Connection Strength
0.879
-
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination. Lancet. 2021 09 18; 398(10305):1041-1042.
Score: 0.241
-
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Rep. 2021 07 20; 36(3):109415.
Score: 0.238
-
Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. PLoS One. 2017; 12(6):e0179177.
Score: 0.180
-
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol. 2011 Dec; 85(24):13363-72.
Score: 0.122
-
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination. Clin Infect Dis. 2021 12 06; 73(11):2000-2008.
Score: 0.061
-
DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry. J Virol. 2014 Oct; 88(20):12087-97.
Score: 0.037